Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy

被引:55
作者
Chabroux, S. [1 ]
Canoui-Poitrine, F. [2 ,3 ,4 ]
Reffet, S. [1 ]
Mills-Joncour, G. [1 ]
Morelon, E.
Colin, C. [2 ,3 ,4 ]
Thivolet, C. [1 ]
机构
[1] Hop Edouard Herriot, Dept Endocrinol, Lyon, France
[2] Hosp Civils Lyon, F-69003 Lyon, France
[3] Univ Lyon 1, F-69003 Lyon, France
[4] Univ Lyon, F-69003 Lyon, France
关键词
Type; 1; diabetes; Complications; Retinopathy; Nephropathy; Neuropathy; Advanced glycation end products; AGE; Skin autofluorescence; SERUM-LEVELS; COMPLICATIONS; RISK; ACCUMULATION; PROGRESSION;
D O I
10.1016/j.diabet.2009.11.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims. Advanced glycation end products (AGEs) are thought to play a central role in the pathogenesis of diabetes complications. For this reason, a non-invasive tool using skin autofluorescence (AF) quantification that correlates with levels of tissue AGEs has been developed. The present study aimed to assess whether or not skin AF is associated with microvascular complications in patients with type 1 diabetes (T1D). Methods. All consecutive patients with T1D (n = 133) had three AF measures taken on the forearm, using illumination with a fluorescent tube, all on the same day after breakfast or lunch. Potential associations between skin AF levels and microvascular complications, age, diabetes duration and health status were then assessed using a multivariate linear-regression model. Results. On age-adjusted analyses, diabetes duration, retinopathy, nephropathy and neuropathy were significantly associated with skin AF levels (all P < 0.001). AF levels increased significantly with severity in both retinopathy and nephropathy (P < 0.001). After adjusting for age, diabetes duration, HbA(1c), smoking, retinopathy, nephropathy and neuropathy, the association of AF levels remained significant with nephropathy and neuropathy, but not with retinopathy and diabetes duration. Conclusion. This study suggests an independent association between skin AF levels and diabetic nephropathy and neuropathy, but not retinopathy, in T1D patients. Prospective studies are needed to confirm the ability of skin AF levels to predict microangiopathy. (c) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:152 / 157
页数:6
相关论文
共 33 条
[1]   The pathobiology of diabetic complications - A unifying mechanism [J].
Brownlee, M .
DIABETES, 2005, 54 (06) :1615-1625
[2]   Advanced glycosylation end products in diabetic renal and vascular disease [J].
Bucala, R ;
Vlassara, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (06) :875-888
[3]   Tobacco smoke is a source of toxic reactive glycation products [J].
Cerami, C ;
Founds, H ;
Nicholl, I ;
Mitsuhashi, T ;
Giordano, D ;
Vanpatten, S ;
Lee, A ;
AlAbed, Y ;
Vlassara, H ;
Bucala, R ;
Cerami, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13915-13920
[4]   Advanced glycation end products, oxidant stress and vascular lesions [J].
Chappey, O ;
Dosquet, C ;
Wautier, MP ;
Wautier, JL .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (02) :97-108
[5]   Advanced glycation end products in children and adolescents with diabetes: Relation to glycemic control and early microvascular complications [J].
Chiarelli, F ;
de Martino, M ;
Mezzetti, A ;
Catino, M ;
Morgese, G ;
Cuccurullo, F ;
Verrotti, A .
JOURNAL OF PEDIATRICS, 1999, 134 (04) :486-491
[6]  
Dorrian CA, 1998, CELL MOL BIOL, V44, P1069
[7]   ACCUMULATION OF MAILLARD REACTION-PRODUCTS IN SKIN COLLAGEN IN DIABETES AND AGING [J].
DYER, DG ;
DUNN, JA ;
THORPE, SR ;
BAILIE, KE ;
LYONS, TJ ;
MCCANCE, DR ;
BAYNES, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2463-2469
[8]  
Furth AJ, 1997, BRIT J BIOMED SCI, V54, P192
[9]  
Genuth S, 1999, DIABETES CARE, V22, P99
[10]   Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes [J].
Genuth, S ;
Sun, WJ ;
Cleary, P ;
Sell, DR ;
Dahms, W ;
Malone, J ;
Sivitz, W ;
Monnier, VM .
DIABETES, 2005, 54 (11) :3103-3111